生物制药公司Cidara Therapeutics, Inc.（股票代码：CDTX）在周四盘后交易中股价飙升36.81%，引发市场广泛关注。这一显著涨幅与可能即将宣布的重大收购交易密切相关。
据市场消息透露，一项对Cidara Therapeutics的溢价收购交易可能将于周五正式宣布。这笔交易的估值预计将超过33亿美元，大幅高于公司当前的市值。如果消息属实，这将是生物技术行业今年最引人注目的交易之一，反映出市场对Cidara在抗感染药物研发领域的高度认可。
投资者对这一潜在交易反应热烈，推动Cidara股价在盘后交易中大幅上涨。然而，公司尚未对这一传闻作出官方回应。市场分析师普遍认为，如果交易最终达成，将为Cidara带来充足的资金支持其研发管线，并可能加速其产品的商业化进程。投资者和业内人士都将密切关注周五的进一步公告，以确认交易细节及其对公司未来发展的影响。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.